Authors: WOHLFARTH K GOSCHEL H FREVERT J DENGLER R BIGALKE H

Citation: K. Wohlfarth et al., DOSE STANDARDIZATION OF BOTULINUM TOXIN - REPLY, Movement disorders, 13(4), 1998, pp. 750-751

Authors: WOHLFARTH K GOSCHEL H DENGLER R BIGALKE H

Citation: K. Wohlfarth et al., BOTULINUM TOXIN - DOSES AND ANTIBODIES, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 433-433

Authors: WOHLFARTH K GOSCHEL H FREVERT J DENGLER R BIGALKE H

Citation: K. Wohlfarth et al., BOTULINUM-A TOXINS - UNITS VERSUS UNITS, Naunyn-Schmiedeberg's archives of pharmacology, 355(3), 1997, pp. 335-340

Authors: GOSCHEL H WOHLFARTH K FREVERT J DENGLER R BIGALKE H

Citation: H. Goschel et al., BOTULINUM A TOXIN THERAPY - NEUTRALIZING AND NONNEUTRALIZING ANTIBODIES-THERAPEUTIC CONSEQUENCES, Experimental neurology, 147(1), 1997, pp. 96-102